Show simple item record

Reversal of Low-Molecular-Weight Heparin Anticoagulation by Synthetic Protamine Analogues

dc.contributor.authorWakefield, Thomas W.en_US
dc.contributor.authorAndrews, Philip C.en_US
dc.contributor.authorWrobleski, Shirley K.en_US
dc.contributor.authorKadell, Amy M.en_US
dc.contributor.authorFazzalari, Antonioen_US
dc.contributor.authorNichol, Brad J.en_US
dc.contributor.authorVanderkooi, Teden_US
dc.contributor.authorStanley, James C.en_US
dc.date.accessioned2006-04-10T18:07:29Z
dc.date.available2006-04-10T18:07:29Z
dc.date.issued1994-06en_US
dc.identifier.citationWakefield, Thomas W., Andrews, Philip C., Wrobleski, Shirley K., Kadell, Amy M., Fazzalari, Antonio, Nichol, Brad J., Vanderkooi, Ted, Stanley, James C. (1994/06)."Reversal of Low-Molecular-Weight Heparin Anticoagulation by Synthetic Protamine Analogues." Journal of Surgical Research 56(6): 586-593. <http://hdl.handle.net/2027.42/31553>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6WM6-45P0G5R-2R/2/c4a0d235722febd0f8d516407d2f8942en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/31553
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8015315&dopt=citationen_US
dc.description.abstractProtamine reversal of unfractionated and low-molecular-weight heparin (LMWH) causes hypotension, bradycardia, pulmonary artery hypertension, and declines in oxygen consumption. Furthermore, protamine incompletely reverses the anti-Xa activity of LMWH. The present study assesses the efficacy and toxicity of three protamine variants having +16 and +18 charges in reversal of LMWH (Logiparin, LHN-1): [+16] P(AK2A2K2)4, [+18] PK(K2A2K2A)3K2AK3, and [+18B] acetyl-PA(K2A2K2A)4K2-amide. The [+18B] compound was made by acetylating and amidating the [+18] to decrease in vivo degradation and to increase the [alpha]-helix forming propensity. Variants were examined in a canine model (n = 7, each variant) and compared to controls (n = 7) reversed with standard protamine with a +21 charge. Animals were anesthetized, anticoagulated with LMWH (150 IU factor Xa activity/kg), and reversed with protamine variants (1.5 mg/kg with 100 IU/mg). Blood pressure (BP), heart rate (HR), cardiac output (CO), pulmonary artery pressures, oxygen saturations, and oxygen consumption (VO2) were continuously monitored. Comparisons were undertaken at baseline, after heparin, before variant administration, and for 30 min thereafter. A total toxicity score (TTS) was calculated for each variant, accounting for maximal declines in BP, HR, CO, and VO2 during the first 5 min after reversal. Protamine [+21] was most toxic, TTS -7.6, with the variants being less toxic (P &lt; 0.01, ANOVA): TTS = [+16] -2.8, [+18] -1.3, and [+18B] -4.1. Percentage reversal of LMWH 3 min after reversal for activated clotting time, anti-factor Xa activity, TCT, and anti-factor Ha activity, respectively, were: [+16] 26, 25, 66, 43%; [+18] 49, 21, 91, 36%; [+18B] 87, 64, 99, 96%; and protamine [+21] 99, 63, 100, 99%. These data document synthetic protamine variant reversal of LMWH anticoagulation. Preventing variant degradation improved efficacy to a level equaling standard protamine, although with some increased toxicity. Nonetheless, all variants were less toxic than protamine.en_US
dc.format.extent468916 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleReversal of Low-Molecular-Weight Heparin Anticoagulation by Synthetic Protamine Analoguesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelSurgery and Anesthesiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumJobst Vascular Laboratory, Section of Vascular Surgery, Department of Surgery, and the Department of Biochemistry, University of Michigan and the Ann Arbor Veterans Administration Medical Center, Ann Arbor, Michigan 48109-0329en_US
dc.contributor.affiliationumJobst Vascular Laboratory, Section of Vascular Surgery, Department of Surgery, and the Department of Biochemistry, University of Michigan and the Ann Arbor Veterans Administration Medical Center, Ann Arbor, Michigan 48109-0329en_US
dc.contributor.affiliationumJobst Vascular Laboratory, Section of Vascular Surgery, Department of Surgery, and the Department of Biochemistry, University of Michigan and the Ann Arbor Veterans Administration Medical Center, Ann Arbor, Michigan 48109-0329en_US
dc.contributor.affiliationumJobst Vascular Laboratory, Section of Vascular Surgery, Department of Surgery, and the Department of Biochemistry, University of Michigan and the Ann Arbor Veterans Administration Medical Center, Ann Arbor, Michigan 48109-0329en_US
dc.contributor.affiliationumJobst Vascular Laboratory, Section of Vascular Surgery, Department of Surgery, and the Department of Biochemistry, University of Michigan and the Ann Arbor Veterans Administration Medical Center, Ann Arbor, Michigan 48109-0329en_US
dc.contributor.affiliationumJobst Vascular Laboratory, Section of Vascular Surgery, Department of Surgery, and the Department of Biochemistry, University of Michigan and the Ann Arbor Veterans Administration Medical Center, Ann Arbor, Michigan 48109-0329en_US
dc.contributor.affiliationumJobst Vascular Laboratory, Section of Vascular Surgery, Department of Surgery, and the Department of Biochemistry, University of Michigan and the Ann Arbor Veterans Administration Medical Center, Ann Arbor, Michigan 48109-0329en_US
dc.contributor.affiliationumJobst Vascular Laboratory, Section of Vascular Surgery, Department of Surgery, and the Department of Biochemistry, University of Michigan and the Ann Arbor Veterans Administration Medical Center, Ann Arbor, Michigan 48109-0329en_US
dc.identifier.pmid8015315en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/31553/1/0000478.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1006/jsre.1994.1093en_US
dc.identifier.sourceJournal of Surgical Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.